Abstract:
Introduction
• The high incidence of ischemic thrombotic cerebrovascular disease (ITCVD), particularly in the elderly, and its debilitating effect in all age groups has made early recognition and prevention of this disease of paramount importance. In the age decade of 60 to 70 years about three individuals per 1000, both men and women, experience ITCVD each year. 1 However, the long incubation period of ITCVD makes it possible to recognize this disease during its covert state. Thus primary prevention can be instituted during the covert stage long in advance of the earliest overt symptomatology, e.g., transient ischemic attacks, in the attempt to prevent or delay the acute episode. This study was designed on the experience gained from a project which resulted in the successful identification of individuals prone to ischemic heart disease (IHD). 2 Since IHD and ITCVD are both atherothrombotic and possess some risk factors in common ( fig. 1) , it was reasonable to extend similar techniques to the identification of individuals prone to ITCVD.
The purpose of this study was to develop an effective tool for classifying individuals prone to ITCVD. Risk factors were selected from a large number of clinical and biochemical variables studied in a retrospective epidemiological study of ITCVD." 4 The technique of multiple discriminant function analysis was then employed to derive a function of the selected risk factors which would best discriminate individuals with covert ITCVD from their healthy counterparts. This communication will report on these findings.
Methods
The study was based on 61 men with ischemic thrombotic cerebrovascular disease (ITCVD) selected from a retrospective stroke study of 364 patients admitted to the Institute of Rehabilitation Medicine, New York University School of Medicine, New York, New York. The criteria for selection were absence of associated overt diseases such as ischemic heart disease, hyperthyroidism, hypothyroidism, diabetes mellitus, gout, and the absence of medications known to influence the carbohydrate metabolism (steroids or thiazides) and lipid metabolism (hypolipemic agents). The diagnosis of each case was confirmed by history, clinical and neurological examinations, lumbar puncture, electroencephalography and/or cerebral angiography. All subjects were ambulatory and at the time of study were participating in an active rehabilitation program. The biochemical and metabolic evaluations were made between one and three months following the acute episode. The healthy male controls were volunteer participants from the New York metropolitan area and were individually age-matched ( ± three years) with Stroke, Vol. 3, Noramber-Otnmbar 1972 each ITCVD subject. In all, a data base of 61 ITCVD men and 61 age-matched male controls was available for the ensuing analysis.
The following measurements were made on all study subjects: systolic and diastolic blood pressures, height, weight and ponderal index. Biochemical determinations, accomplished on fasting serum, were total cholesterol, lipid phosphorus, triglycerides, and uric acid. A threehour oral glucose tolerance test (GTT) was administered to each study subject. Blood glucose, plasma immunoreactive insulin (IRI), free fatty acid (FFA) and lactate levels were determined at fasting, and following ingestion of the equivalent of 75 gm of glucose in the form of Glucola (Ames Co. Inc., Elkhart, Indiana) at one-half, one, two and three hours. The methods for these determinations are described elsewhere.
The continuous variables, e.g., cholesterol, uric acid, etc., were individually compared between the ITCVD group and the age-matched control group for a difference in the mean, using a two-tailed /-test where applicable. The categorical variables, e.g., presence or absence of hypertension, normal or abnormal electrocardiogram (EKG) and lipoprotein patterns, were tested for discriminating power with a chi-square analysis. All study variables showing differences between the two groups were considered risk factors of ITCVD and were included in the multivariate discriminant analysis. In cases where one or more data items were missing, the grand mean of the variable was inserted for the missing data.
The linear discriminant function analysis of the risk factors was accomplished in a stepwise manner, i.e., at each step of the analysis all the variables not yet entered into the function were tested to select the next most discriminating variable. In addition, the F ratio was calculated and tested to insure that each risk factor in the function contributed significantly to the discrimination between the diseased and healthy groups. The stepwise procedure was terminated when the remaining variables provided no additional contribution to the overall discrimination.
Denoting the inverse of the pooled variancecovariance matrix by o-1J , the discriminant function coefficients (C | ) are calculated by i and the constant term
where Xji-> is the mean of the jth variable in the ITCVD group and Xj (1) in the control group. The discriminant function is then written Y = SC ( for an individual in the units of those variables used to derive the function. The C, are the discriminant function coefficients described by Fisher in 1936 which are derived to maximize the ratio of variance between two samples relative to the variance within the samples. 6 The discriminant function is derived so that the best criterion of classification is a function (profile) score greater than zero for patients who are "ITCVD prone" and less than zero for those who are "non-ITCVD prone." However, if the a priori probability of an individual belonging to one of the two groups is known, i.e., the probability of ITCVD in the general population, then the criterion of classification is the log e (PI/P-J)-where p 2 is the probability of ITCVD and Pi non-ITCVD, i.e., pj = 1 -p 2 . 7 An individual is then classified as "ITCVD prone" if his calculated function score is greater than log e (Pi/P).
The transformation of a discriminant function into a multiple logistic function has been described, 8 ' ° resulting in the risk function
where P denotes the conditional probability or risk and C o and C, are as defined above. This calculation of the multiple logistic function with the term log e (Pi/p 2 ) is equivalent to the classification criteria when the a priori probability is that the individual will experience the overt disease.
Results

SELECTION OF RISK FACTORS OF ITCVD
The 61 ITCVD men and 61 age-matched controls were compared for significant differences in the mean in order to select the risk factors of ITCVD from the clinical and biochemical variables evaluated in this study (table 1) . No significant differences were found in height, weight, ponderal index, cholesterol and lipid phosphorus levels between the diseased and the control groups. The variables showing a significant difference between the ITCVD group and the agematched control group were considered individual risk factors and were entered consequently into the discriminant function analysis. Significantly elevated systolic and diastolic blood pressures, elevated glucose, triglyceride and uric acid levels, abnormal IRI, FFA and lactate response in ITCVD indicate that any one of these variables can be considered as an individual risk factor and may be predictive of ITCVD. Chi-square analyses of lipoprotein patterns, history of hypertension, and electrocardiograms revealed a significantly greater prevalence of these abnormalities in ITCVD than in control subjects (table 2) .
MULTIVARIATE ANALYSIS OF RISK FACTORS
The discriminant function analysis, calculated in a stepwise manner as described in Methods, selected six variables which in the function analysis displayed the greatest discriminating power (table 3) . The order in which the variables are entered into the discriminant function is determined by their relative discriminating power dependent on the variables previously entered. The weight or contribution of each variable in the discriminant function is expressed as a standardized coefficient, derived by multiplying the function coefficient by the standard deviation of that variable. This reflects the positive or negative contribution of each variable corresponding to a change of one standard deviation.
In order to evaluate the discriminant function of these six risk factors, the function score was calculated for each ITCVD and control subject. The scores for each group were arranged in ascending order and the cumulative percentage was calculated over the range of the score values. Figure 2 shows the graph of cumulative percentages for the ITCVD subjects and 100% minus the cumulative percentage for the controls. Using zero as the criterion for separation of the two groups, subjects with a positive score, i.e., greater than zero, were classified as "ITCVD prone," whereas subjects with a negative score were classified "non-ITCVD prone." According to this discriminant function seven of the controls and ten of the ITCVD subjects were misclassified. This resulted in correct classification of 86.1% of the study population.
Since all the distributions of the continuous variables show a positive skew of varying degree, a logarithmic transformation was performed on each of these variables, which eliminated the skewness from the distributions and made them more normal or Gaussian. The transformed data base then was used to calculate a second discriminant function, which included the same variables selected in the first function with the addition of the three-hour glucose level. However, the addition of this one variable and the use of the logarithmic transformation classified correctly only one 
FIGURE 2
Cumulative percentages of the discriminant function scores for ITCVD and control subjects.
additional subject. Thus, this function correctly classified 86.9% of the subjects versus 86.1% by the preceding function.
DEVELOPMENT OF A PROFILE OF THE ITCVD-PRONE INDIVIDUAL
Since several variables reflecting glucose tolerance are included in the above functions, i.e., blood glucose one-half hour, two-hour and three-hour levels, and two measures of hypertension, i.e., personal history of hypertension and systolic blood pressure, it was thought that little discriminating power would be lost by employing only one measure each for the functions. (2) Systolic blood pressure was included rather than hypertension because elevated levels are indicators of hypertension and small changes are correspondingly reflected in the function score. (3) The lipoprotein classification had a strong standardized coefficient in the preceding functions. (4) The glucose two-hour level is the best indicator of glucose intolerance since it has the strongest standardized coefficient of all the glucose values during the GTT. The discriminant function analysis of the four variables, now designated as primary risk factors of ITCVD, is shown in table 4. Again, using zero as the best criterion for discriminating between the ITCVD and controls, only 11 ITCVD subjects and eight control subjects were misclassified, resulting in correct classification of 84.4% of the subjects. Since the resulting function (profile) score glucose tolerance and the blood pressure. Therefore, a third discriminant function was calculated and the rationale for the inclusion of only four variables is as follows: (1) IRI three-hour level is the most powerful individual discriminator shown by the previous two value is less than zero, the subject is classified as "non-ITCVD prone." Employing this same subject, the transformation of his discriminant function score of -1.5 into an actual probability (P) of ITCVD is accomplished as follows: Therefore the conditional probability of ITCVD in this subject is 0.00067, which is below the assumed risk for the entire population. such as diastolic blood pressure, uric acid, triglycerides, FFA and lactate three-hour levels, and EKG abnormalities demonstrate univariate discriminating power, but when each is included in the multivariate function as an additional variable to the set of more powerful discriminators, its additional contribution in the classification of ITCVD-prone individuals is not significant. However, it must be remembered that each of these variables may be considered clinically as an indicator of covert ITCVD.
IDENTIFICATION OF THE ITCVD-PRONE INDIVIDUAL
There are major differences as well as some similarities in the risk factors which enable one to classify ischemic heart disease (IHD) and ITCVD from each other and from other individuals in the population ( fig. 1 ).
0.033 X (55) +0.039 x (160) + 2.48 X (2) + 0.020 X (150) -13.3 = 2.7.
The function score of 2.7 being greater than zero classifies the subject as "ITCVD prone." Transforming this score by the multiple logistic function yields a probability of ITCVD of 0.04, i.e., This value indicates that the subject is (0.04/0.003) = 13 times more vulnerable to ITCVD than the average individual in the population.
Discussion
There have been various publications concerning the risk factors of ITCVD derived from prospective studies. 10 ' u These publications included as risk factors hypertension, diabetes mellitus, hyperlipoproteinemia, and possibly hyperuricemia, which are consistent with the individual risk factors shown in tables 1 and 2. Since a complete evaluation of carbohydrate metabolism including a GTT was made in this study, the role of impaired glucose tolerance and elevated IRI response was found to be most important in the delineation of the known risk factors. Accordingly, only those variables which contribute significantly to the overall classification of ITCVD are included in the risk function used for the selection of ITCVDprone individuals.
The entire set of variables in tables 1 and 2 which show significant differences can be considered as risk factors of ITCVD. Variables
The differences are chiefly in the lipids, e.g., cholesterol and phospholipids, which are elevated in IHD and in the two-hour postprandial glucose and the three-hour IRI levels which are elevated to a greater extent in ITCVD. Thus, it may be said that IHD is primarily a disease of abnormal lipid metabolism, whereas ITCVD is more of a disease of disordered carbohydrate metabolism. The elevation of systolic blood pressure is common to both diseases, but the strength of its contribution varies, with the emphasis probably in ITCVD. This may be due in part to age differences inasmuch as the ITCVD patients are on the average ten years older than patients with IHD.
It appears from the standardized coefficients in table 3 that the history of hypertension is a more powerful discriminator than systolic blood pressure. However, there are two possible explanations for this: Since the diseased and age-matched control subjects are in the seventh decade and it is known that some parameters approximate each other, e.g., cholesterol at older ages, thus a history of hypertension which reflects the blood pressure at a younger age is a stronger discriminator. Furthermore, it is possible that blood pressure is subjected to therapy either directly or indirectly during the earliest part of hospitalization which tends to reflect in a lower mean systolic blood pressure for the ITCVD subjects. 
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The impaired glucose tolerance and abnormal IRI response in ITCVD are shown in table 1, and both of these risk factors contributed significantly to the discriminant functions. Since carbohydrate metabolism had not been evaluated in these subjects prior to this study, there was little or no manipulation which would affect the glucose tolerance of these patients. Consequently the glucose and IRI measurements are probably unbiased. Furthermore, ITCVD subjects with a history of diabetes mellitus were excluded from the study.
Even though the triglyceride and uric acid levels were significantly higher in ITCVD subjects than in control subjects, these individual risk factors did not enter the discriminant function. However, they are probably reflected in the greater number of abnormal lipoprotein patterns found in ITCVD of which they form a strong component. Thus, the strong contribution of lipoproteins to the discriminant function is accounted for by the combined effect of these risk factors.
Caution must be used, however, in transferring these results to other populations. The data utilized in constructing these discriminant functions were collected retrospectively in the ITCVD subjects. Therefore, the sample of ITCVD patients studied reflects the characteristics of those individuals who survived the acute thrombotic cerebrovascular episode. Furthermore, they were within the age range and demonstrated the physical and mental ability required to undergo an active rehabilitation program. However, care was taken to evaluate the patients in this study after the acute manifestations of the disease had subsided and the patients were metabolically stable.
This presentation has demonstrated the feasibility of classifying the individual with covert ITCVD from the putatively healthy population with the use of only four primary risk factors. The importance of finding the candidate for ITCVD should be evaluated in three areas: (1) primary prevention, (2) secondary prevention, and (3) future research studies.
Primary prevention can only be a reality when the candidate for ITCVD is identified. This communication offers such a possibility. The method of intervention therapy will depend upon the degree of abnormality in the 770 risk factors and in the risk factors themselves. Thus, it may be necessary to reduce the blood pressure and impose restrictions in order to control the abnormal carbohydrate metabolism by either diet, medication or exercise. It may be necessary to initiate preventive anticoagulation therapy. In the cases of advanced cerebral artery occlusion it also may be necessary to employ surgical means to restore the blood supply to its near-full capacity. This can be achieved during the covert stage if symptoms and signs suggest that this procedure is indicated.
The problem of secondary prevention revolves along similar principles as that described under primary prevention. In this instance, there is a completed incident of ITCVD. The main purpose at hand is to restore the most efficient functional level that the individual can possibly achieve from the resultant pathological changes. In addition to initiating medical rehabilitative procedures, it also is mandatory to institute secondary prevention, the purpose of which is to delay the onset of further acute episodes of ITCVD. It should be emphasized that unless secondary prevention is practiced concomitantly with an ongoing active rehabilitation program, the success of the latter will fail to reach its objective in terms of long-term amelioration of the illness and restoration of the optimal physiological functions. Thus, every patient undergoing rehabilitation should be evaluated for any co-existing or underlying illness, e.g., diabetes mellitus or hypertension, as well as for the presence of abnormal risk factors.
The identification of the ITCVD-prone individual offers an additional discipline for study. This would enable one to study and assess additional factors which could be associated with or perhaps even be causally related to ITCVD in individuals who are ITCVD prone and in whom one is reasonably certain that the disease is incubating. This offers a unique possibility to study still unknown factors in a very efficient manner, because it enables one to concentrate his efforts in those cases with high probability of having an overt incidence of ITCVD rather than studying all healthy individuals as one would attempt in a classical prospective epidemiological study. 
